from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1523/-

LFCtreatmentdescriptionclass of inhibitor

0.221

Amikacinug/mL Amikacintranslation

1.073

Cap5-10ug/mL Capreomycintranslation

-0.324

Rox10-50 ug/mL Roxithromycintranslation

0.992

SM2-5 ug/mL Streptomycintranslation

1.630

Tet5-10 ug/mL Tetracyclinetranslation

0.328

Rif0.2-5ug/mL Rifampicintranscription

0.905

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.855

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.193

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.124

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.926

Clofazimine10-13 ug/mL Clofaziminerespiration

0.040

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.312

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.936

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.749

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.075

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.545

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.352

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.779

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.465

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.601

KCN5-20 ug/mL Potassium cyaniderespiration

-0.214

NaN30.2-2 mM Sodium aziderespiration

-0.028

Nigericin50 uM Nigericinrespiration

-0.280

TRC10-150 ug/mL Triclosanrespiration

-1.032

TRZ10-25 ug/mL Thioridazinerespiration

-1.849

Valinomycin0.5-10 uM Valinomycinrespiration

1.200

ZnSO42 mM ZnSO4respiration

-0.262

menadione6-10 ug/mL Menadionerespiration

-1.004

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.708

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.244

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.286

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.645

NRP_1Non-replicating persistence stage 1dosRassociated

0.380

Amp0.2mg/mL AmpicillincellWall

0.863

Cephalexin20-100 ug/mL CephalexincellWall

1.134

Cerulenin0.32-5 ug/mL CerulenincellWall

0.546

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.631

EMB10-20 ug/mL EthambutolcellWall

1.291

Eta12-40 ug/mL EthionamidecellWall

1.022

INH0.2-0.4 ug/mL IsoniazidcellWall

0.483

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.202

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.629

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.328

BZA0.12 mg/mL BenzamidearomaticAmides

0.281

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.327

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.010

H2O24 mM hydrogen peroxideDNAdamaging

0.550

Levo10 ug/mL LevofloxacinDNAdamaging

0.387

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.423

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.275

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.155

UVUV-irradiationDNAdamaging

-0.924

ARP41-4 ug/mL Antitubercular compound ARP4?

0.541

Antimycin12.5-50 ug/mL Antimycin A?

0.287

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.674

PA_110-50 ug/mL Antitubercular compound PA-1?

1.033

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.767

PA8240.2-2 ug/mL PA-824?

-0.465

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.087

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.043

Verapamil50 uM Verapamil?

0.126

mercaptoethanol2 mM 2-Mercaptoethanol?

0.188

methoxatin10-20 ug/mL Methoxatin?